Innovations in The Management of Diabetes: Next generation treatments and market dynamics

Diabetes has become the fifth leading cause of death across developed markets, and cases of the disease are forecast to grow by 7.1% across the globe by 2013. The market for innovative diabetes treatments will be driven by this projected rise in prevalence, together with the substantial unmet need for drugs that can effectively halt or reverse disease progression.

Although extended lifecycle management for existing antidiabetic therapies may offer sales growth in the short term, the development of new drugs from novel classes will become increasingly important in the future. However, the potential introduction of stricter regulations for diabetes drug development and recent setbacks for novel products have increased speculation about the potential of innovative treatments.

Read more...

• Key Asia Pacific Markets (30/06/2009)
• Top 5 Emerging Markets (05/06/2009)
• Schizophrenia (29/05/2009)

• Obesity Drug Markets (14/10/2008)
• Valuing Pharmaceutical Innovation (14/10/2008)
• The Anti-Infectives Market Outlook to 2013 (14/10/2008)
• Respiratory Disorders (14/10/2008)
• Monoclonal Antibodies Report (14/10/2008)
• EU Pharmaceutical Forum (11/10/2008)
• Neuropathic Pain (10/10/2008)
• Non-hormonal Treatments for Menopausal Symptoms (10/10/2008)
• Rx-to-OTC Strategies (10/10/2008)

---